Our invention helps relieve diabetic nerve pain, sciatic pain, fibromyalgia pain & spinal cord injury nerve pain without significant side effects or ADR. Our cutting edge research for Stroke, Traumatic Brain & Spinal Cord injury (TBI/SCI) survivors - helps in accelerated motor recovery, significant cognitive & sensory improvements Patients at risk of developing Ischemic stroke taking our invention have shown significant reduction in infarct size as compared to those not taking it We have demonstrated significant improvement in working memory & cognition in patients with Early stage Alzheimer's Diseases

By 2030, the proportion of total global deaths due to chronic lifestyle diseases is expected to increase to 70 per cent and the global burden of disease to 56 per cent. The chronic diseases are related to unhealthy diet and nutrition amongst many other factors and present the greatest public health burden, either in terms of direct cost to society and government, or in terms of disability adjusted life years (DALYs). To name few prominent ones -Diabetes, Coronary Heart Diseases(CHD) , Ischemic Brain Diseases, Non Alcoholic Fatty Liver Diseases (NAFLD), Alzheimer’s Disease, Neurodegenerative diseases, Neuropathies, Chronic Kidney Diseases (CKD).

Different Areas of Research

CELAGENEX has developed cutting edge technology platform that combines clinically proven unique biological metabolites (compounds) & bioavailability enhancers to regulate cellular metabolism.


The company has protected the discovery and application of its portfolio through extensive IP that includes thirteen issued and or filed and allowed to date with corresponding patents pending globally.

Targeted Therapies

Our specially targeted therapies are able to show demonstrable results leading to remarkable improvements in,

Neuronal Health

Cardiac Health

Hepatic Heath


Metabolic Syndrome

Implantation Science